Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New Wnt signaling inhibitors JW-74 and JW-67 inhibit tumor growth in vivo

Jan. 19, 2011

Naftopidil has effects on stromal and cancer cells

Jan. 19, 2011

Phase I/II trial of Mologen's MGN-1601 in renal cancer cleared to admit all patients

Jan. 18, 2011

Phase I trial to evaluate hydroxychloroquine to block autophagy in cancer

Jan. 18, 2011

Lorus Therapeutics begins phase I trial of anticancer candidate LOR-253

Jan. 18, 2011

MMRF and Synta Pharma to codevelop ganetespib for multiple myeloma

Jan. 18, 2011

MedImmune begins phase I MEDI-565 trial in gastrointestinal cancers

Jan. 17, 2011

ChemGenex notifies EMA of withdrawal of MAA for Tekinex for Ph+ CML

Jan. 17, 2011

SCV-07 advances in phase IIb trial for prevention of oral mucositis in head and neck cancer

Jan. 17, 2011

Threshold Pharma claims new camptothecin derivatives for cancer therapy

Jan. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...